These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 36267231)
1. Calcitonin gene-related peptide predicts therapeutic response to midodrine hydrochloride in children with vasovagal syncope. Li L; Zhao H; Ma X; Jiao F; Lin J Front Neurosci; 2022; 16():1026539. PubMed ID: 36267231 [TBL] [Abstract][Full Text] [Related]
2. Serum uric acid predicts therapeutic response to midodrine hydrochloride in children with vasovagal syncope: a pilot study. Du X; Li X; Zhang C; Liu P; Wang Y; Zhang Q; Du J; Liao Y; Jin H Eur J Pediatr; 2024 Jan; 183(1):371-378. PubMed ID: 37904034 [TBL] [Abstract][Full Text] [Related]
3. [Efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope]. Liu XY; Wang C; Wu LJ; Hu CY; Lin P; Li MX; Cui XL; Xie ZW Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1951-4. PubMed ID: 19950567 [TBL] [Abstract][Full Text] [Related]
4. The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope. Qingyou Z; Junbao D; Chaoshu T J Pediatr; 2006 Dec; 149(6):777-80. PubMed ID: 17137891 [TBL] [Abstract][Full Text] [Related]
5. Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome. Zhang F; Li X; Ochs T; Chen L; Liao Y; Tang C; Jin H; Du J J Am Coll Cardiol; 2012 Jul; 60(4):315-20. PubMed ID: 22813609 [TBL] [Abstract][Full Text] [Related]
6. Baroreflex Sensitivity Predicts Response to Metoprolol in Children With Vasovagal Syncope: A Pilot Study. Tao C; Li X; Tang C; Jin H; Du J Front Neurosci; 2019; 13():1329. PubMed ID: 31920498 [No Abstract] [Full Text] [Related]
7. [Predictive value of blood cell parameters in the diagnosis of vasovagal syncope in children]. Zhang J; Tang HN; Wang YW; Li F; Cai H; Lin P; Zou RM; Wang C Zhonghua Er Ke Za Zhi; 2022 Aug; 60(8):792-797. PubMed ID: 35922190 [No Abstract] [Full Text] [Related]
8. Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis. Lei LY; Raj SR; Sheldon RS Europace; 2022 Jul; 24(7):1171-1178. PubMed ID: 35025999 [TBL] [Abstract][Full Text] [Related]
9. The predictive value of urine specific gravity in the diagnosis of vasovagal syncope in children and adolescents. Liu P; Zeng X; Mei W; Wang Y; Zou R; Wang C Ital J Pediatr; 2021 Apr; 47(1):93. PubMed ID: 33865429 [TBL] [Abstract][Full Text] [Related]
10. Plasma copeptin and therapeutic effectiveness of midodrine hydrochloride on postural tachycardia syndrome in children. Zhao J; Tang C; Jin H; Du J J Pediatr; 2014 Aug; 165(2):290-294.e1. PubMed ID: 24857518 [TBL] [Abstract][Full Text] [Related]
11. Midodrine treatment in children with recurrent vasovagal syncope. Bagrul D; Ece I; Yılmaz A; Atik F; Kavurt AV Cardiol Young; 2021 May; 31(5):817-821. PubMed ID: 33407967 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial). Romme JJ; van Dijk N; Go-Schön IK; Reitsma JB; Wieling W Europace; 2011 Nov; 13(11):1639-47. PubMed ID: 21752826 [TBL] [Abstract][Full Text] [Related]
13. Postural orthostatic tachycardia syndrome with increased erythrocytic hydrogen sulfide and response to midodrine hydrochloride. Yang J; Zhao J; Du S; Liu D; Fu C; Li X; Chen S; Tang C; Du J; Jin H J Pediatr; 2013 Oct; 163(4):1169-73.e2. PubMed ID: 23726544 [TBL] [Abstract][Full Text] [Related]
14. Midodrine hydrochloride in the treatment of vasovagal syncope. Mitro P; Trejbal D; Rybár AR Pacing Clin Electrophysiol; 1999 Nov; 22(11):1620-4. PubMed ID: 10598965 [TBL] [Abstract][Full Text] [Related]
15. [Comparative efficacy and tolerance of atenolol and midodrine in patients with vasovagal syncopes]. Kuchinskaia EA; Pevzner AV; Vershuta EV; Al'bitskaia KV; Kheĭmets GI; Rogoza AN; Golitsyn SP Ter Arkh; 2006; 78(4):64-8. PubMed ID: 16821426 [TBL] [Abstract][Full Text] [Related]
16. Twenty-four-hour urine NE level as a predictor of the therapeutic response to metoprolol in children with recurrent vasovagal syncope. Kong Q; Yang X; Cai Z; Pan Y; Wang M; Liu M; Zhao C Ir J Med Sci; 2019 Nov; 188(4):1279-1287. PubMed ID: 30761458 [TBL] [Abstract][Full Text] [Related]
17. Acceleration Index Predicts Efficacy of Orthostatic Training on Vasovagal Syncope in Children. Tao C; Li X; Tang C; Jin H; Du J J Pediatr; 2019 Apr; 207():54-58. PubMed ID: 30528576 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy. Sra J; Maglio C; Biehl M; Dhala A; Blanck Z; Deshpande S; Jazayeri MR; Akhtar M J Cardiovasc Electrophysiol; 1997 Jan; 8(1):42-6. PubMed ID: 9116967 [TBL] [Abstract][Full Text] [Related]
19. Plasma Neuropeptide Y Levels in Vasovagal Syncope in Children. Liao Y; Xu WR; Li HX; Tang CS; Jin HF; Du JB Chin Med J (Engl); 2017 Dec; 130(23):2778-2784. PubMed ID: 29176136 [TBL] [Abstract][Full Text] [Related]
20. [Association of vitamin D deficiency with severity of symptoms in children with vasovagal syncope]. Kong YJ; Bian P; Yang YN; Dong T; Niu SM; Yuan SJ; Dong XY Zhonghua Er Ke Za Zhi; 2022 Jun; 60(6):557-561. PubMed ID: 35658362 [No Abstract] [Full Text] [Related] [Next] [New Search]